Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

Endometriosis causes chronic pain and fatigue when tissue similar to the womb lining grows outside the uterus. With diagnosis often taking up to 9 years, the availability of additional treatment ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...

A daily pill to treat the symptoms of endometriosis will soon be made available on the NHS, in a move that could benefit 1000 women a year in England.1 The National Institute for Health and Care ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating ...